Ardelyx Investigative Site 225 — Hartsdale, New York

Ardelyx Investigative Site 225 is a clinical research site located in Hartsdale, New York, United States 10530.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Ardelyx Investigative Site 225 has participated in 1 clinical trials.

Therapeutic areas: Constipation Predominant Irritable Bowel Syndrome.

Sponsors: Ardelyx.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ardelyx Investigative Site 225?

Ardelyx Investigative Site 225 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ardelyx Investigative Site 225 conducted?

Ardelyx Investigative Site 225 has 1 clinical trials on record. Their work covers Constipation Predominant Irritable Bowel Syndrome.

Is Ardelyx Investigative Site 225 accredited by Crixeo Health?

Ardelyx Investigative Site 225 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ardelyx Investigative Site 225?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.